ROSSITTO, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 4.245
AS - Asia 2.068
EU - Europa 1.388
AF - Africa 552
SA - Sud America 456
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 24
Totale 8.795
Nazione #
US - Stati Uniti d'America 3.927
SG - Singapore 701
HK - Hong Kong 353
CN - Cina 323
BR - Brasile 279
IT - Italia 260
DE - Germania 125
FI - Finlandia 99
SE - Svezia 94
VN - Vietnam 93
PL - Polonia 91
GB - Regno Unito 89
RU - Federazione Russa 64
NL - Olanda 58
IN - India 55
FR - Francia 53
UG - Uganda 33
CA - Canada 32
IQ - Iraq 30
UA - Ucraina 29
AR - Argentina 28
PA - Panama 27
EC - Ecuador 26
ES - Italia 26
ID - Indonesia 26
MX - Messico 26
UZ - Uzbekistan 25
IE - Irlanda 24
JM - Giamaica 24
CY - Cipro 23
MY - Malesia 23
BJ - Benin 22
DZ - Algeria 22
JP - Giappone 22
KR - Corea 22
PY - Paraguay 22
AU - Australia 21
NI - Nicaragua 21
PK - Pakistan 21
PT - Portogallo 21
TR - Turchia 21
BY - Bielorussia 20
EE - Estonia 20
PH - Filippine 20
BZ - Belize 19
LB - Libano 19
MA - Marocco 19
PE - Perù 19
RS - Serbia 19
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 18
AZ - Azerbaigian 18
BE - Belgio 18
JO - Giordania 18
MD - Moldavia 18
AT - Austria 17
GM - Gambi 17
HU - Ungheria 17
TT - Trinidad e Tobago 17
ZA - Sudafrica 17
BA - Bosnia-Erzegovina 16
BF - Burkina Faso 16
BO - Bolivia 16
CH - Svizzera 16
CO - Colombia 16
CV - Capo Verde 16
GE - Georgia 16
LC - Santa Lucia 16
LY - Libia 16
MN - Mongolia 16
NP - Nepal 16
PR - Porto Rico 16
SK - Slovacchia (Repubblica Slovacca) 16
GN - Guinea 15
IL - Israele 15
MK - Macedonia 15
MR - Mauritania 15
MZ - Mozambico 15
NO - Norvegia 15
TH - Thailandia 15
TN - Tunisia 15
AO - Angola 14
CU - Cuba 14
CZ - Repubblica Ceca 14
HN - Honduras 14
KE - Kenya 14
ME - Montenegro 14
MG - Madagascar 14
TW - Taiwan 14
UY - Uruguay 14
ZM - Zambia 14
BG - Bulgaria 13
CD - Congo 13
CI - Costa d'Avorio 13
CL - Cile 13
CW - ???statistics.table.value.countryCode.CW??? 13
DO - Repubblica Dominicana 13
GF - Guiana Francese 13
KG - Kirghizistan 13
KH - Cambogia 13
Totale 8.215
Città #
Fairfield 575
Singapore 462
Ashburn 437
Hong Kong 345
Woodbridge 288
Ann Arbor 248
Chandler 246
Houston 241
Seattle 186
Cambridge 172
Wilmington 151
Beijing 130
Santa Clara 95
Boardman 92
Padova 79
Los Angeles 71
Bytom 63
San Diego 60
New York 56
Medford 49
Princeton 49
Chicago 47
Helsinki 44
Munich 44
Roxbury 35
Des Moines 32
Kampala 32
Buffalo 31
São Paulo 27
Ho Chi Minh City 26
Nanjing 26
Panama City 26
Hefei 22
Tashkent 22
Cotonou 20
Dublin 20
Managua 20
Milan 20
Dong Ket 19
Amman 16
Nuremberg 16
Padua 16
Ulan Bator 16
Castries 15
Conakry 15
Kingston 15
Lappeenranta 15
London 15
Salt Lake City 15
Chennai 14
Guangzhou 14
Havana 14
Limassol 14
Maputo 14
Podgorica 14
Redondo Beach 14
Seoul 14
Baku 13
Kuala Lumpur 13
Lusaka 13
Minsk 13
Montevideo 13
Nairobi 13
Nouakchott 13
Ouagadougou 13
Rio de Janeiro 13
Tallinn 13
Turku 13
Warsaw 13
Abidjan 12
Antananarivo 12
Baghdad 12
Bamako 12
Brooklyn 12
Harare 12
Jacksonville 12
Montreal 12
Phnom Penh 12
Praia 12
Tbilisi 12
Amsterdam 11
Chisinau 11
Hanoi 11
Lima 11
Accra 10
Andorra la Vella 10
Asunción 10
Bridgetown 10
Kigali 10
Skopje 10
Toronto 10
Tripoli 10
Willemstad 10
Athens 9
Bangkok 9
Banjul 9
Belize City 9
Bishkek 9
Boston 9
Brazzaville 9
Totale 5.359
Nome #
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 235
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 210
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 194
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension 193
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 189
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 186
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 184
Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease. 180
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study 179
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 174
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 169
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 166
'Essential' arterial hypertension: time for a paradigm change 165
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 161
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 158
Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade 157
Oral burning with dysphagia and weight loss 156
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 156
Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution 154
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 152
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 152
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 150
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 148
Elevation of Angiotensin-II Type-1-Receptor Autoantibodies Titer in Primary Aldosteronism as a Result of Aldosterone-Producing Adenoma. 146
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 146
Management of hypertensive emergencies: a practical approach 146
Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism 143
Modern Management of Hypertensive Emergencies 139
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 137
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 135
Lymphatic vessels and the renin-angiotensin-system 134
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 132
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 132
Cell-mediated autoimmune mechanisms involved in the pathogenesis of primary aldosteronism. 127
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 127
Clinical Outcomes of 1625 Patients with Primary Aldosteronism Subtyped with Adrenal Vein Sampling 125
Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. 122
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 115
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 114
Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large Multiethnic International Study 110
Primary Aldosteronism and Drug Resistant Hypertension: A "Chicken-Egg" Story 108
A Worrying and Puzzling Case of Hypertension Presenting to the Emergency Department 107
Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism 107
Tissue sodium excess is not hypertonic and reflects extracellular volume expansion 105
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 104
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study 104
Tangram of Sodium and Fluid Balance 99
Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction 99
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 99
Q: Should alpha-blockers ever be used as antihypertensive drugs? 94
Skin-specific mechanisms of body fluid regulation in hypertension 87
Clinical Management of Primary Aldosteronism: An Update 86
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 85
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling 82
Haemodynamic assessment in hypertension: the soloists and the orchestra 82
Sodium, Interstitium, Lymphatics and Hypertension-A Tale of Hydraulics 81
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism 80
Antibodies to malondialdehyde oxidized LDL predict cardiovascular events during long-term follow-up in high risk coronary artery disease patients. 79
Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review 77
Dr Giacomo Rossitto interviews Professor Rhian Touyz, on the translational applications of vascular smooth muscle cell biology in cardiovascular disease 77
Coronary sinus diameter to estimate congestion and predict survival 75
Ipertensione e surrene 74
Much Ado about N⋯ atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localized oedema 74
Does Excess Tissue Sodium Storage Regulate Blood Pressure? 73
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 72
The Lymphatic System 68
Pathophysiology of Hypertension 65
Aldosterone and Cardiovascular Damage: a New Lesson From an Old Study 64
Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism" 61
Antihypertensive Drugs and Vascular Health 61
Response to the letter regarding the hypothesis paper “Much ado about N . . . Atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localised oedema” 58
Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats 56
Of Snails, Earthworms, and Men: Insights into Strategies to Preserve Water 51
Mechanisms of sodium-mediated injury in cardiovascular disease: old play, new scripts 38
Totale 8.930
Categoria #
all - tutte 29.702
article - articoli 28.646
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.056
Totale 59.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021794 0 0 0 0 22 11 141 50 72 245 44 209
2021/2022707 24 45 38 62 62 93 37 52 48 54 34 158
2022/2023570 114 46 26 44 86 58 7 44 80 27 26 12
2023/2024345 16 40 42 32 17 41 23 15 21 13 33 52
2024/20251.834 12 148 96 43 185 43 166 161 116 130 278 456
2025/20263.412 408 512 993 1.358 141 0 0 0 0 0 0 0
Totale 8.930